Regenstrief Research Scientist Alexia M. Torke, M.D., M.S., described how chaplain support care for family members in charge of making tough decisions for their loved ones in the ICU can help improve their overall mental health.
New Regenstrief Institute President and CEO Rachel Patzer, PhD, MPH, explained how using data and institute-wide resources can play a prominent role in finding solutions for health inequities across the U.S.
Regenstrief Institute Research Scientist Joshua R. Vest, PhD, MPH, revealed that housing instability and financial strain might not be accurately flagged by electronic health record screeners in a study published in JAMA.
Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
Regenstrief Research Scientist Marianne Matthias, PhD, explained EQUIPD (Equity Using Interventions for Pain and Depression), a two-phase study funded by the NIH HEAL Initiative that will address racial disparities in chronic pain and depression.
Regenstrief Research Scientist Alexia Torke, M.D., MS, explained how proactive, enhanced spiritual care led to better spiritual and psychological outcomes for caregivers of ICU patients.
Regenstrief Research Scientist Joshua R. Vest, PhD, MPH, explained that electronic health record screening questionnaires don’t accurately identify common barriers to health equity like housing instability or financial strain.
Regenstrief Research Scientist Malaz Boustani, M.D., explained the development of a passive digital marker that helps identify people at risk for Alzheimer’s disease and related dementias.
Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., described how a Regenstrief-created framework would act as a ‘measuring stick’ to provide consistent guidelines to assess the accuracy of patient matching algorithms.
Regenstrief Research Scientist Titus Schleyer, DMD, PhD, explained findings from a study that provides a snapshot of FHIR app development efforts.